DPI-287
From Wikipedia, the free encyclopedia
|
DPI-287
|
|
| Systematic (IUPAC) name | |
| 4-[(R)-[(2S,5R)-2,5-dimethyl-4-benzylpiperazin-1-yl]-(3-hydroxyphenyl)methyl]-N,N-diethylbenzamide | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C31H39N3O2 |
| Mol. mass | 485.659 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
DPI-287 is a drug which is used in scientific research. It is a highly selective agonist for the δ-opioid receptor which produces less convulsions than most drugs from this family.[1] It has antidepressant effects.[2]
[edit] References
- ^ Jutkiewicz EM. The antidepressant -like effects of delta-opioid receptor agonists. Molecular Interventions. 2006 Jun;6(3):162-9. PMID 16809477
- ^ Jutkiewicz EM, Chang KJ, Rice KC, Woods JH. (2005) Characterization of a novel nonpeptide delta-opioid agonist analog DPI287 with antidepressant-like activity. Experimental Biology meeting abstracts. FASEB J. 19, Abstract # 874.4

